Cyclophilin inhibitors in Hepatitis C viral Infection | Debio 025 | / | Publications

Menu Content/Inhalt

Home|Careers|Contact us

News

20.11.2008
Debiopharm and Aurigene sign licensing agreement for the development and commercialisation of Debio 0617, a novel inhibitor of an undisclosed oncology pathway
17.11.2008
Debiopharm and Pharmaleads sign license agreement for Debio 0827 or PL37 in treatment of chronic pain conditions

Cyclophilin inhibitors in Hepatitis C viral Infection

Robert Flisiak, Jean-Maurice Dumont & Raf Crabbé

EXPERT OPINION September 2007, Vol. 16, No. 9, Pages 1345-1354